Skip to content

The Effect Of Date Palm Pollen Capsul On Sexual Function In Menopausal Woman

The Effect Of Date Palm Pollen Capsul On Sexual Function In Menopausal Woman: A randomized controlled clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016070928853N1
Enrollment
60
Registered
2016-12-09
Start date
2016-08-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Function In Menopausal Woman. Unspecified sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Control group: be taken daily 300 mg placebo capsules for 35 days. Intervention 2: Interventional group: be taken daily 300 mg oral Date Palm Pollen capsules for 35 days.
Treatment - Drugs
Placebo
Control group: be taken daily 300 mg placebo capsules for 35 days.
Interventional group: be taken daily 300 mg oral Date Palm Pollen capsules for 35 days.

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Iranian women, Fifth grade of Elementary School, age 40-65 years for a research unit or her Spouse, Women with natural menopause, Married women and having sex at least once a month, desire to participate in the research. Exclusion criteria: Having any sexual dysfunction before menopause, Known medical conditions affecting sexual function in research unit or her Spouse, Research Unit or her Spouse have Consumption Drugs affecting sexual performance during the past three months, Experience some unpleasant or stressful life events in the past 6 months by the Research Unit or her Spouse, Research Unit have to be sensitive to pollen and medicinal plants, treated with hormonal drug, Research Unit or her Spouse addiction to drugs or alcohol.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual Function. Timepoint: Before intervention and 35 day after taking the capsules. Method of measurement: Female Sexual Function Index(FSFI).

Secondary

MeasureTime frame
Sexual Function. Timepoint: Before intervention and 35 day after taking the capsules. Method of measurement: Femal Sex Function Index.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaye Sadeghi Goghari

Faculty of Nursing and Midwifery, Mashhad

Sadeghis922@mums.ac.ir+98 917 575 0127

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026